Cantitate/Preț
Produs

Understanding Liver Cancer: A Tale of Two Diseases

Autor Brian I. Carr
en Limba Engleză Paperback – 31 iul 2014
​Understanding Liver Cancer is a concise and up-to-date review, which discusses diagnosis, management, patient care, current and emerging therapies, and useful resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of liver cancer as well as a summary of current therapies will benefit from this succinct text.
Citește tot Restrânge

Preț: 31539 lei

Preț vechi: 33199 lei
-5% Nou

Puncte Express: 473

Preț estimativ în valută:
6036 6383$ 5035£

Carte tipărită la comandă

Livrare economică 30 decembrie 24 - 13 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781910315019
ISBN-10: 191031501X
Pagini: 50
Ilustrații: XV, 50 p. 7 illus., 4 illus. in color.
Dimensiuni: 210 x 279 x 7 mm
Greutate: 0.18 kg
Ediția:2014
Editura: Springer
Colecția Springer Healthcare
Locul publicării:Tarporley, United Kingdom

Public țintă

Professional/practitioner

Cuprins

1. Introduction to hepatocellular carcinoma -Introduction, incidence and geography, causes of hepatocellular carcinoma, prevention, surveillance screening, biology of human hepatocellular carcinoma.2. Clinical disease evaluation - Diagnosis A: Radiology, Diagnosis B: Blood tests, tumor markers, Diagnosis C: Biopsy - a debate, assessment of tumour extent for treatment planning: staging classifications, the new patient assessment.3. Management of hepatocellular carcinoma - General treatment choices, therapies with curative intent, non-curative therapies, systemic drugs, assessment of responses to therapy: what do tumor size responses signify?4. The whole patient setting - Therapy decisions for the individual patient: importance of a multidisciplinary team approach, psychosocial considerations, family, support groups.5. New directions6. Addendum - Abbreviations, extended.

Caracteristici

Reviews the current treatment recommendations for liver cancer and emerging treatment options based on recent clinical trials, per specific patient groups
Easily accessible text, tables, figures, and images exemplify the disease, staging, varying patient groups, and treatment algorithms
Highlighted take-home messages and key points reinforce the most important topics of each section, giving the reader a comprehensive review
Includes supplementary material: sn.pub/extras